(Q34619438)

English

Pramipexole for the treatment of depressive symptoms in patients with Parkinson's disease: a randomised, double-blind, placebo-controlled trial

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

3 August 2017

Pramipexole for the treatment of depressive symptoms in patients with Parkinson's disease: a randomised, double-blind, placebo-controlled trial (English)

1 reference

Europe PubMed Central

3 August 2017

0 references

0 references

Parkinson's disease

1 reference

based on heuristic

inferred from title

2

object named as

Werner Poewe

1 reference

Europe PubMed Central

3 August 2017

1

object named as

Paolo Barone

1 reference

Europe PubMed Central

3 August 2017

7

object named as

Eduardo Tolosa

1 reference

Europe PubMed Central

3 August 2017

6

object named as

Olivier Rascol

1 reference

Europe PubMed Central

3 August 2017

Daniel A Weintraub

8

object named as

Daniel Weintraub

1 reference

Europe PubMed Central

3 August 2017

Stefan Albrecht

3

object named as

Stefan Albrecht

1 reference

Europe PubMed Central

3 August 2017

Catherine Debieuvre

4

object named as

Catherine Debieuvre

1 reference

Europe PubMed Central

3 August 2017

author name string

Dan Massey

5

1 reference

Europe PubMed Central

3 August 2017

publication date

7 May 2010

1 reference

Europe PubMed Central

3 August 2017

Lancet Neurology

1 reference

Europe PubMed Central

3 August 2017

9

1 reference

Europe PubMed Central

3 August 2017

6

1 reference

Europe PubMed Central

3 August 2017

573-580

1 reference

Europe PubMed Central

3 August 2017

A systematic review of prevalence studies of depression in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970106-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Quality of life and depression in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970106-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Depression and Parkinson's disease: a review

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970106-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical correlates of depressive symptoms in familial Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970106-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Depression in Parkinson's disease: loss of dopamine and noradrenaline innervation in the limbic system

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970106-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Therapies for depression in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970106-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Antidepressant studies in Parkinson's disease: a review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970106-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Evidence-based medical review update: pharmacological and surgical treatments of Parkinson's disease: 2001 to 2004

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970106-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of desipramine and citalopram treatments for depression in Parkinson's disease: a double-blind, randomized, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970106-X

7 January 2021

based on heuristic

inferred from DOI database lookup

A controlled trial of antidepressants in patients with Parkinson disease and depression

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970106-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Pramipexole and pergolide in the treatment of depression in Parkinson's disease: a national multicentre prospective randomized study.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970106-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Sustained administration of pramipexole modifies the spontaneous firing of dopamine, norepinephrine, and serotonin neurons in the rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970106-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Reversal of stress-induced anhedonia by the dopamine receptor agonist, pramipexole.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970106-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Antidepressant effects of pramipexole, a novel dopamine receptor agonist

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970106-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Pramipexole versus sertraline in the treatment of depression in Parkinson's disease: a national multicenter parallel-group randomized study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970106-X

7 January 2021

based on heuristic

inferred from DOI database lookup

The effect of pramipexole on mood and motivational symptoms in Parkinson's disease: a meta-analysis of placebo-controlled studies

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970106-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Depression rating scales in Parkinson's disease: critique and recommendations

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970106-X

7 January 2021

based on heuristic

inferred from DOI database lookup

What features improve the accuracy of clinical diagnosis in Parkinson's disease: A clinicopathologic study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970106-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Parkinsonism: onset, progression, and mortality

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970106-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Test characteristics of the 15-item geriatric depression scale and Hamilton depression rating scale in Parkinson disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970106-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of age on geriatric depression scale performance in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970106-X

7 January 2021

based on heuristic

inferred from DOI database lookup

“Mini-mental state”

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970106-X

7 January 2021

based on heuristic

inferred from DOI database lookup

An Inventory for Measuring Depression

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970106-X

7 January 2021

based on heuristic

inferred from DOI database lookup

The Parkinson's Disease Questionnaire (PDQ-39): development and validation of a Parkinson's disease summary index score.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970106-X

7 January 2021

based on heuristic

inferred from DOI database lookup

EuroQol--a new facility for the measurement of health-related quality of life

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970106-X

7 January 2021

based on heuristic

inferred from DOI database lookup

A scale for the assessment of hedonic tone the Snaith-Hamilton Pleasure Scale.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970106-X

7 January 2021

based on heuristic

inferred from DOI database lookup

The significance of treating somatic symptoms on functional outcome improvement in patients with major depressive disorder: a post hoc analysis of 2 trials

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970106-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Reliability and validity of the Beck depression inventory in patients with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970106-X

7 January 2021

based on heuristic

inferred from DOI database lookup

The impact of treatment of depression on quality of life, disability and relapse in patients with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970106-X

7 January 2021

based on heuristic

inferred from DOI database lookup

The role of dopamine in the pathophysiology of depression

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970106-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Antidepressant drug effects and depression severity: a patient-level meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970106-X

7 January 2021

based on heuristic

inferred from DOI database lookup

The clinically important difference on the unified Parkinson's disease rating scale.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970106-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S1474-4422(10)70106-X

1 reference

Europe PubMed Central

3 August 2017

1 reference

Europe PubMed Central

3 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34619438&oldid=2062053362"